Latest news with #ZhuhaiCosMXBattery
Yahoo
29-07-2025
- Business
- Yahoo
Asian Stocks Trading Below Estimated Value For July 2025
As global markets respond positively to recent trade deals, Asian stocks are gaining attention amid hopes for continued economic stability and growth. In this environment, identifying undervalued stocks can be a strategic move for investors seeking opportunities in the region's evolving market landscape. Top 10 Undervalued Stocks Based On Cash Flows In Asia Name Current Price Fair Value (Est) Discount (Est) Zhuhai CosMX Battery (SHSE:688772) CN¥14.21 CN¥27.87 49% Xi'an NovaStar Tech (SZSE:301589) CN¥155.04 CN¥309.43 49.9% SpiderPlus (TSE:4192) ¥506.00 ¥993.77 49.1% Polaris Holdings (TSE:3010) ¥220.00 ¥433.42 49.2% LigaChem Biosciences (KOSDAQ:A141080) ₩139900.00 ₩277418.79 49.6% Hibino (TSE:2469) ¥2370.00 ¥4686.23 49.4% Guangdong Marubi Biotechnology (SHSE:603983) CN¥40.40 CN¥78.51 48.5% GEM (SZSE:002340) CN¥6.69 CN¥13.14 49.1% Fositek (TWSE:6805) NT$883.00 NT$1737.53 49.2% cottaLTD (TSE:3359) ¥435.00 ¥852.54 49% Click here to see the full list of 261 stocks from our Undervalued Asian Stocks Based On Cash Flows screener. Let's uncover some gems from our specialized screener. OrbusNeich Medical Group Holdings Overview: OrbusNeich Medical Group Holdings Limited is involved in the manufacturing, trading, sales, and marketing of medical devices for coronary and peripheral vascular diseases across multiple regions including Japan, Europe, the Middle East, Africa, Asia Pacific, China, and the United States with a market cap of HK$4.18 billion. Operations: The company's revenue from its Surgical & Medical Equipment segment is $164.10 million. Estimated Discount To Fair Value: 43.4% OrbusNeich Medical Group Holdings is trading at HK$5.07, significantly below its estimated fair value of HK$8.96, suggesting it may be undervalued based on cash flows. With expected annual earnings growth of 21.9%, surpassing the Hong Kong market's average, and revenue growth projected at 8.9% per year, the company shows potential for appreciation despite a forecasted low return on equity of 15.7%. Recent dividend affirmations further bolster investor confidence. Upon reviewing our latest growth report, OrbusNeich Medical Group Holdings' projected financial performance appears quite optimistic. Unlock comprehensive insights into our analysis of OrbusNeich Medical Group Holdings stock in this financial health report. True Corporation Overview: True Corporation Public Company Limited, along with its subsidiaries, offers telecommunications and value-added services in Thailand with a market cap of THB373.16 billion. Operations: The company generates revenue from several segments, including Mobile at THB171.52 billion, Pay TV at THB6.79 billion, and Broadband Internet and Others at THB27.79 billion. Estimated Discount To Fair Value: 29.2% True Corporation, trading at THB10.8, is undervalued relative to its estimated fair value of THB15.25 and trades 29.2% below this estimate based on discounted cash flow analysis. Despite a forecasted annual revenue decline of 0.5%, earnings are expected to grow significantly by 71.07% per year, outpacing the market average and indicating potential for profitability within three years. Recent leadership changes may influence strategic direction positively amidst these financial dynamics. Our growth report here indicates True Corporation may be poised for an improving outlook. Take a closer look at True Corporation's balance sheet health here in our report. Zhuhai CosMX Battery Overview: Zhuhai CosMX Battery Co., Ltd. is a global manufacturer and supplier of polymer lithium-ion batteries, with a market cap of CN¥15.99 billion. Operations: Zhuhai CosMX Battery Co., Ltd. generates its revenue from the manufacturing and supply of polymer lithium-ion batteries on a global scale. Estimated Discount To Fair Value: 49% Zhuhai CosMX Battery, priced at CN¥14.21, is significantly undervalued against its fair value estimate of CN¥27.87 based on discounted cash flow analysis, trading 49% below this value. Despite a high debt level and low forecasted return on equity of 15%, its earnings are projected to grow by over 40% annually for the next three years, surpassing market expectations and highlighting strong potential for profitability improvement despite a modest dividend coverage. Our earnings growth report unveils the potential for significant increases in Zhuhai CosMX Battery's future results. Navigate through the intricacies of Zhuhai CosMX Battery with our comprehensive financial health report here. Make It Happen Get an in-depth perspective on all 261 Undervalued Asian Stocks Based On Cash Flows by using our screener here. Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments. Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe. Ready To Venture Into Other Investment Styles? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:6929 SET:TRUE and SHSE:688772. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Melden Sie sich an, um Ihr Portfolio aufzurufen.
Yahoo
29-07-2025
- Business
- Yahoo
3 Asian Stocks Estimated To Be Trading At Up To 38.4% Below Fair Value
As global markets respond positively to new trade deals and economic indicators, Asian stocks are capturing attention with their potential value. In this environment, identifying undervalued stocks can offer opportunities for investors seeking to capitalize on discrepancies between market prices and perceived intrinsic values. Top 10 Undervalued Stocks Based On Cash Flows In Asia Name Current Price Fair Value (Est) Discount (Est) Zhuhai CosMX Battery (SHSE:688772) CN¥14.07 CN¥27.82 49.4% SpiderPlus (TSE:4192) ¥498.00 ¥993.27 49.9% Shenzhen Envicool Technology (SZSE:002837) CN¥31.65 CN¥62.15 49.1% Range Intelligent Computing Technology Group (SZSE:300442) CN¥51.51 CN¥101.65 49.3% Polaris Holdings (TSE:3010) ¥221.00 ¥433.91 49.1% HL Holdings (KOSE:A060980) ₩40950.00 ₩81254.09 49.6% HDC Hyundai Development (KOSE:A294870) ₩23000.00 ₩45711.05 49.7% GEM (SZSE:002340) CN¥6.68 CN¥13.13 49.1% Forum Engineering (TSE:7088) ¥1206.00 ¥2404.16 49.8% cottaLTD (TSE:3359) ¥433.00 ¥851.54 49.2% Click here to see the full list of 263 stocks from our Undervalued Asian Stocks Based On Cash Flows screener. Here's a peek at a few of the choices from the screener. Sanil Electric Overview: Sanil Electric Co., Ltd. manufactures and sells transformers in Korea and internationally, with a market cap of ₩3.01 billion. Operations: Sanil Electric's revenue is primarily derived from its Electric Equipment segment, totaling ₩362.18 million. Estimated Discount To Fair Value: 10.5% Sanil Electric, trading at ₩98,900, is considered undervalued with a fair value estimate of ₩110,444.76. The company's earnings are projected to grow significantly at 23.7% annually over the next three years, outpacing the Korean market average of 20.9%. Revenue growth is also expected to exceed market averages at 22.4% per year. Despite high non-cash earnings and a strong forecasted return on equity of 27%, its undervaluation margin remains modest at 10.5%. The analysis detailed in our Sanil Electric growth report hints at robust future financial performance. Dive into the specifics of Sanil Electric here with our thorough financial health report. BMC Medical Overview: BMC Medical Co., Ltd. focuses on the research, development, manufacturing, and supply of respiratory health medical equipment and consumables in China with a market cap of CN¥7.91 billion. Operations: The company's revenue primarily comes from its Surgical & Medical Equipment segment, which generated CN¥915.44 million. Estimated Discount To Fair Value: 36.1% BMC Medical is trading at CN¥88.99, significantly undervalued with a fair value estimate of CN¥139.29, offering potential for investors focused on cash flow valuation. Despite low forecasted return on equity of 10% in three years, its earnings are expected to grow robustly at 27.5% annually, outpacing the Chinese market's average growth rate. Recent product-related announcements highlight BMC's expanding international presence and innovation in digital health solutions, potentially enhancing future revenue streams. The growth report we've compiled suggests that BMC Medical's future prospects could be on the up. Delve into the full analysis health report here for a deeper understanding of BMC Medical. Fuji Overview: Fuji Corporation, with a market cap of ¥246.79 billion, manufactures and sells machines and machine tools in Japan. Operations: The company's revenue is primarily derived from its Robotic Solutions segment at ¥114.21 billion and Machine Tools segment at ¥11.09 billion. Estimated Discount To Fair Value: 38.4% Fuji, trading at ¥2808, is significantly undervalued with a fair value estimate of ¥4558.69. Its earnings are forecasted to grow at 20.8% annually, surpassing the Japanese market average. Despite a low future return on equity of 9.4%, revenue growth is expected to outpace the market at 9.5% per year. Recent completion of a share buyback program and stable dividend affirmations reflect strategic financial management aimed at enhancing shareholder value amidst leadership changes. Our growth report here indicates Fuji may be poised for an improving outlook. Click here to discover the nuances of Fuji with our detailed financial health report. Where To Now? Discover the full array of 263 Undervalued Asian Stocks Based On Cash Flows right here. Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments. Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage. Searching for a Fresh Perspective? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include KOSE:A062040 SZSE:301367 and TSE:6134. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
28-07-2025
- Business
- Yahoo
3 Asian Stocks Estimated To Be Trading At Up To 38.4% Below Fair Value
As global markets respond positively to new trade deals and economic indicators, Asian stocks are capturing attention with their potential value. In this environment, identifying undervalued stocks can offer opportunities for investors seeking to capitalize on discrepancies between market prices and perceived intrinsic values. Top 10 Undervalued Stocks Based On Cash Flows In Asia Name Current Price Fair Value (Est) Discount (Est) Zhuhai CosMX Battery (SHSE:688772) CN¥14.07 CN¥27.82 49.4% SpiderPlus (TSE:4192) ¥498.00 ¥993.27 49.9% Shenzhen Envicool Technology (SZSE:002837) CN¥31.65 CN¥62.15 49.1% Range Intelligent Computing Technology Group (SZSE:300442) CN¥51.51 CN¥101.65 49.3% Polaris Holdings (TSE:3010) ¥221.00 ¥433.91 49.1% HL Holdings (KOSE:A060980) ₩40950.00 ₩81254.09 49.6% HDC Hyundai Development (KOSE:A294870) ₩23000.00 ₩45711.05 49.7% GEM (SZSE:002340) CN¥6.68 CN¥13.13 49.1% Forum Engineering (TSE:7088) ¥1206.00 ¥2404.16 49.8% cottaLTD (TSE:3359) ¥433.00 ¥851.54 49.2% Click here to see the full list of 263 stocks from our Undervalued Asian Stocks Based On Cash Flows screener. Here's a peek at a few of the choices from the screener. Sanil Electric Overview: Sanil Electric Co., Ltd. manufactures and sells transformers in Korea and internationally, with a market cap of ₩3.01 billion. Operations: Sanil Electric's revenue is primarily derived from its Electric Equipment segment, totaling ₩362.18 million. Estimated Discount To Fair Value: 10.5% Sanil Electric, trading at ₩98,900, is considered undervalued with a fair value estimate of ₩110,444.76. The company's earnings are projected to grow significantly at 23.7% annually over the next three years, outpacing the Korean market average of 20.9%. Revenue growth is also expected to exceed market averages at 22.4% per year. Despite high non-cash earnings and a strong forecasted return on equity of 27%, its undervaluation margin remains modest at 10.5%. The analysis detailed in our Sanil Electric growth report hints at robust future financial performance. Dive into the specifics of Sanil Electric here with our thorough financial health report. BMC Medical Overview: BMC Medical Co., Ltd. focuses on the research, development, manufacturing, and supply of respiratory health medical equipment and consumables in China with a market cap of CN¥7.91 billion. Operations: The company's revenue primarily comes from its Surgical & Medical Equipment segment, which generated CN¥915.44 million. Estimated Discount To Fair Value: 36.1% BMC Medical is trading at CN¥88.99, significantly undervalued with a fair value estimate of CN¥139.29, offering potential for investors focused on cash flow valuation. Despite low forecasted return on equity of 10% in three years, its earnings are expected to grow robustly at 27.5% annually, outpacing the Chinese market's average growth rate. Recent product-related announcements highlight BMC's expanding international presence and innovation in digital health solutions, potentially enhancing future revenue streams. The growth report we've compiled suggests that BMC Medical's future prospects could be on the up. Delve into the full analysis health report here for a deeper understanding of BMC Medical. Fuji Overview: Fuji Corporation, with a market cap of ¥246.79 billion, manufactures and sells machines and machine tools in Japan. Operations: The company's revenue is primarily derived from its Robotic Solutions segment at ¥114.21 billion and Machine Tools segment at ¥11.09 billion. Estimated Discount To Fair Value: 38.4% Fuji, trading at ¥2808, is significantly undervalued with a fair value estimate of ¥4558.69. Its earnings are forecasted to grow at 20.8% annually, surpassing the Japanese market average. Despite a low future return on equity of 9.4%, revenue growth is expected to outpace the market at 9.5% per year. Recent completion of a share buyback program and stable dividend affirmations reflect strategic financial management aimed at enhancing shareholder value amidst leadership changes. Our growth report here indicates Fuji may be poised for an improving outlook. Click here to discover the nuances of Fuji with our detailed financial health report. Where To Now? Discover the full array of 263 Undervalued Asian Stocks Based On Cash Flows right here. Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments. Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage. Searching for a Fresh Perspective? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include KOSE:A062040 SZSE:301367 and TSE:6134. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
25-07-2025
- Business
- Yahoo
Asian Value Stocks Trading At Estimated Discounts In July 2025
As of July 2025, Asian markets are witnessing a mix of modest gains and challenges, with Japan's stock markets showing slight increases despite political uncertainties and China's economic growth easing pressures for immediate stimulus. In this environment, identifying undervalued stocks becomes crucial as investors seek opportunities that offer potential value amidst fluctuating market conditions and evolving economic indicators. Top 10 Undervalued Stocks Based On Cash Flows In Asia Name Current Price Fair Value (Est) Discount (Est) Zhuhai CosMX Battery (SHSE:688772) CN¥14.09 CN¥28.02 49.7% SpiderPlus (TSE:4192) ¥508.00 ¥993.55 48.9% Shin Maint HoldingsLtd (TSE:6086) ¥1166.00 ¥2320.85 49.8% Polaris Holdings (TSE:3010) ¥218.00 ¥431.56 49.5% KeePer Technical Laboratory (TSE:6036) ¥3420.00 ¥6784.50 49.6% HL Holdings (KOSE:A060980) ₩40650.00 ₩80385.88 49.4% Hibino (TSE:2469) ¥2346.00 ¥4674.18 49.8% GEM (SZSE:002340) CN¥6.74 CN¥13.27 49.2% Forum Engineering (TSE:7088) ¥1208.00 ¥2407.94 49.8% cottaLTD (TSE:3359) ¥432.00 ¥852.18 49.3% Click here to see the full list of 261 stocks from our Undervalued Asian Stocks Based On Cash Flows screener. Let's review some notable picks from our screened stocks. Overview: Tsinghua Tongfang Co., Ltd. operates in digital information, civil nuclear technology, energy conservation and environmental protection, and technology and finance sectors, with a market cap of CN¥25.29 billion. Operations: The company's revenue segments include digital information, civil nuclear technology, energy conservation and environmental protection, and technology and finance. Estimated Discount To Fair Value: 45.5% Tsinghua Tongfang is trading at a significant discount to its estimated fair value, with a current price of CN¥7.55 compared to the fair value estimate of CN¥13.86. Despite recent financial challenges, including a net loss of CN¥287.6 million in Q1 2025 and declining revenue, the stock's long-term prospects are buoyed by forecasted earnings growth exceeding 93% annually over the next three years, outpacing both industry and market averages in China. SHSE:600100 Discounted Cash Flow as at Jul 2025 Overview: Fujian Longking Co., Ltd. manufactures and sells environmental protection equipment globally, with a market cap of CN¥15.66 billion. Operations: The company's revenue segments include the manufacture and sale of environmental protection equipment worldwide.
